STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic
STAAR Surgical Company (STAA)
Last staar surgical company earnings: 2/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=71327&p=irol-irhome
Company Research
Source: PR Newswire
MONROVIA, Calif., May 11, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, has received CE Mark for its EVO+ Visian ICL™ with Aspheric (EDOF) Optic, for commercialization in the European Union from its Notified Body, DEKRA. The EVO+ Visian ICL with Aspheric (EDOF) Optic is STAAR's next-generation lens. The lens is surgically implanted and works in harmony with the patient's eye to correct vision. Unlike traditional contact lenses that are placed on the surface of the eye, the EVO Visian ICL family of lenses is positioned inside the eye between the iris and the natural lens where it stays indefinitely. The EVO+ Visian ICL with Aspheric (EDOF) Optic is indicated for the correction or reduction of hyperopia and myopia between +3.0 diopters and -18.0 diopters. These lenses include CentraFLOW® technology, a central port that allows the flow of aqueous humor, thus el
Show less
Read more
Impact Snapshot
Event Time:
STAA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STAA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STAA alerts
High impacting STAAR Surgical Company news events
Weekly update
A roundup of the hottest topics
STAA
News
- The Crowd: Jeremy Poincenot, the World Blind Golf Champion, speaks at Beyond Blindness event [Los Angeles Times (CA)]Los Angeles Times
- STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Mizuho from $45.00 to $53.00. They now have a "buy" rating on the stock.MarketBeat
- STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $32.00 to $46.00. They now have a "hold" rating on the stock.MarketBeat
- STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.MarketBeat
- Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
STAA
Earnings
- 2/26/24 - Beat
STAA
Sec Filings
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- STAA's page on the SEC website